B BIO-TECHNE CORP
| Market Cap | $8.31B |
| P/E Ratio | 100.25 |
| Forward P/E | 24.44 |
| Dividend Yield | 0.60% |
| Beta | 1.49 |
| 52W Range | $46.47 - $71.28 |
| # Hedge Funds | 5 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 5 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Wallace Weitz Weitz Investment Management | 2.80% | $47.22M | 802,950 | Add 0.10% |
| Lee Ainslie Maverick Capital | 2.43% | $226.47M | 3,850,923 | Add 27.82% |
| Mairs & Power Growth Fund Mairs & Power Inc | 1.57% | $162.76M | 2,767,539 | Reduce 1.42% |
| Ruane Cunniff Ruane Cunniff & Goldfarb | 1.35% | $86.21M | 1,465,935 | Reduce 0.53% |
| Henry Ellenbogen Durable Capital Partners | 1.16% | $122.85M | 2,088,891 | Add 49.64% |
Insider Trading
| Insider Name of the company insider who made the trade 1 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Herr Amy E. | Sale | 1,976 | $59.11 | $116.79K | 17 Feb 2026 | 19 Feb 2026 |
Frequently Asked Questions
What is TECH stock price today?
BIO-TECHNE CORP (TECH) is currently trading at $53.13. The stock has a 52-week range of $46.47 to $71.28 and a market capitalization of $8.31B.
Is TECH a good stock to buy in 2026?
BIO-TECHNE CORP has a P/E ratio of 100.2 (forward P/E: 24.4), a dividend yield of 0.60%, and 1-year performance of -2.6%. 5 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling TECH stock?
There have been 1 insider transactions for TECH in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has TECH stock performed over the past year?
BIO-TECHNE CORP (TECH) has returned -2.6% over the past 12 months. The stock traded between $46.47 and $71.28 during this period, and is currently at $53.13.
Which hedge funds own TECH (BIO-TECHNE CORP)?
5 tracked hedge funds currently hold TECH in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is TECH's market cap and valuation?
BIO-TECHNE CORP (TECH) has a market capitalization of $8.31B. The trailing P/E ratio is 100.2 and forward P/E is 24.4. The stock is classified in the Healthcare sector.
What is TECH's revenue and profitability?
BIO-TECHNE CORP reported revenue of $1.22B with net income of $81.06M and a profit margin of 0.07%. The stock has a beta of 1.49.
What sector is TECH in and who are its biggest institutional holders?
BIO-TECHNE CORP (TECH) operates in the Healthcare sector. It is held by 5 tracked hedge funds. See the ownership table above for the complete list.